Viewing StudyNCT00004213



Ignite Creation Date: 2024-05-05 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004213
Status: COMPLETED
Last Update Posted: 2013-07-18
First Post: 2000-01-28

Brief Title: 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
Sponsor: Vion Pharmaceuticals
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: VION-CLI-001-2
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Vion Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators